Acker Merrall & Condit Announces Grande Fête de Bourgogne
Jan 24, 2018 21:04 pm UTC| Business
NEW YORK, Jan. 24, 2018 -- Acker Merrall Condit, the world’s leading wine auctioneer and authority on fine and rare wine, has announced a week-long celebration dedicated to the wines of Burgundy, those who make them,...
Iovance Biotherapeutics, Inc. Announces Public Offering of Common Stock
Jan 24, 2018 21:02 pm UTC| Business
SAN CARLOS, Calif., Jan. 24, 2018 -- Iovance Biotherapeutics, Inc. (Nasdaq:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced...
SI Financial Group, Inc. Increases Wages and Dividend
Jan 24, 2018 21:02 pm UTC| Business
WILLIMANTIC, Conn., Jan. 24, 2018 -- SI Financial Group, Inc. (the “Company”) (NASDAQ:SIFI), the parent of Savings Institute Bank and Trust Company (the “Bank”), announced plans to raise minimum wages for approximately...
Texas Capital Bancshares, Inc. Announces Operating Results for 2017
Jan 24, 2018 21:02 pm UTC| Business
DALLAS, Jan. 24, 2018 -- Texas Capital Bancshares, Inc. (NASDAQ:TCBI), the parent company of Texas Capital Bank, announced earnings and operating results for the fourth quarter and full year of 2017. “We are pleased...
Jan 24, 2018 21:01 pm UTC| Business
Three of Eight Evaluable Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with LN-145 Experienced a Confirmed Partial Response One of Two Evaluable Patients...
ConforMIS Announces Proposed Public Offering of Common Stock
Jan 24, 2018 21:01 pm UTC| Business
BILLERICA, Mass., Jan. 24, 2018 -- ConforMIS, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement...
Albireo Announces Proposed Public Offering of Common Stock
Jan 24, 2018 21:01 pm UTC| Business
BOSTON, Jan. 24, 2018 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today that it has commenced an underwritten public...